These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12509431)

  • 1. Orientation of 1,3-bisphosphoglycerate analogs bound to phosphoglycerate kinase.
    Jakeman DL; Ivory AJ; Blackburn GM; Williamson MP
    J Biol Chem; 2003 Mar; 278(13):10957-62. PubMed ID: 12509431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly potent bisphosphonate ligands for phosphoglycerate kinase.
    Jakeman DL; Ivory AJ; Williamson MP; Blackburn GM
    J Med Chem; 1998 Nov; 41(23):4439-52. PubMed ID: 9804684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the R65Q mutant of yeast 3-phosphoglycerate kinase complexed with Mg-AMP-PNP and 3-phospho-D-glycerate.
    McPhillips TM; Hsu BT; Sherman MA; Mas MT; Rees DC
    Biochemistry; 1996 Apr; 35(13):4118-27. PubMed ID: 8672447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoglycerate kinase acts as a futile cycle at high temperature.
    Kouril T; Eicher JJ; Siebers B; Snoep JL
    Microbiology (Reading); 2017 Nov; 163(11):1604-1612. PubMed ID: 28982396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of substrates and other anions to yeast phosphoglycerate kinase.
    Scopes RK
    Eur J Biochem; 1978 Nov; 91(1):119-29. PubMed ID: 363424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graphical analyses on binding of ligands to a two-sited system. Theoretical treatments exemplified on yeast phosphoglycerate kinase.
    Larsson-Raźnikiewicz M
    Arch Biochem Biophys; 1973 Oct; 158(2):754-62. PubMed ID: 4592987
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of ATP analogs with yeast 3-phosphoglycerate kinase. Affinity labeling of the hinge region.
    Pineda T; Kwon OS; Serpersu EH; Churchich JE
    Eur J Biochem; 1993 Mar; 212(3):719-26. PubMed ID: 8462545
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Serimbetov Z; Baxter NJ; Cliff MJ; Waltho JP
    Biomol NMR Assign; 2017 Oct; 11(2):251-256. PubMed ID: 28866776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observation of strange kinetics in protein folding.
    Sabelko J; Ervin J; Gruebele M
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6031-6. PubMed ID: 10339536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 31P NMR study of bound reactants and products of yeast 3-phosphoglycerate kinase at equilibrium and the effect of sulfate ion.
    Rao BD; Cohn M; Scopes RK
    J Biol Chem; 1978 Nov; 253(22):8056-60. PubMed ID: 361736
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular basis of the unusual catalytic preference for GDP/GTP in Entamoeba histolytica 3-phosphoglycerate kinase.
    Encalada R; Rojo-Domínguez A; Rodríguez-Zavala JS; Pardo JP; Quezada H; Moreno-Sánchez R; Saavedra E
    FEBS J; 2009 Apr; 276(7):2037-47. PubMed ID: 19292872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic, binding, and NMR studies of perdeuterated yeast phosphoglycerate kinase and its interactions with substrates.
    Shibata CG; Gregory JD; Gerhardt BS; Serpersu EH
    Arch Biochem Biophys; 1995 May; 319(1):204-10. PubMed ID: 7771785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proton-NMR study of a site-directed mutation (His388----Glu) in the interdomain region of yeast phosphoglycerate kinase. Implications for domain movement.
    Graham HC; Williams RJ; Littlechild JA; Watson HC
    Eur J Biochem; 1991 Mar; 196(2):261-9. PubMed ID: 2007400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic binding of substrates to 3-phosphoglycerate kinase monitored by the fluorescent analogue 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate.
    Vas M; Merli A; Rossi GL
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):885-91. PubMed ID: 8053912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate inhibition of phosphoglycerate kinase: quantitative structure-activity relationship and pharmacophore modeling investigation.
    Kotsikorou E; Sahota G; Oldfield E
    J Med Chem; 2006 Nov; 49(23):6692-703. PubMed ID: 17154500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MgF
    McCormick NE; Forget SM; Syvitski RT; Jakeman DL
    Biochem Cell Biol; 2017 Apr; 95(2):295-303. PubMed ID: 27991832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational changes in yeast phosphoglycerate kinase upon ligand binding: fluorescence of a linked probe and chemical reactivity of genetically introduced cysteinyl residues.
    Desmadril M; Minard P; Ballery N; Gaillard-Miran S; Hall L; Yon JM
    Proteins; 1991; 10(4):315-24. PubMed ID: 1946341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast glyceraldehyde-3-phosphate dehydrogenase. Evidence that subunit cooperativity in catalysis can be controlled by the formation of a complex with phosphoglycerate kinase.
    Ashmarina LI; Muronetz VI; Nagradova NK
    Eur J Biochem; 1985 May; 149(1):67-72. PubMed ID: 3888624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of distances in yeast phosphoglycerate kinase molecules using saturation effect ESR spectra at 77 K].
    Vlasova II; Kuprin SP
    Biofizika; 1992; 37(5):927-34. PubMed ID: 1335291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immobilized glyceraldehyde-3-phosphate dehydrogenase forms a complex with phosphoglycerate kinase.
    Ashmarina LI; Muronetz VI; Nagradova NK
    Biochem Int; 1984 Oct; 9(4):511-21. PubMed ID: 6393989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.